These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37426884)

  • 1. Effect of phthalocyanine oral and nasal antiseptic solutions on the infectivity of SARS-CoV-2 in patients with COVID-19: a randomized controlled trial.
    Colado Simão AN; Perugini Stadtlober N; Stinghen Garcia Lonni AA; Venâncio LM; Lerner Trigo G; de Souza Cassela PLC; Mastellini Sanches Silva T; De Fátima Oliveira Hirth Ruiz M; Batisti Lozovoy MA; Tano ZN; da Fonseca Orcina B; Vieira Vilhena F; da Silva Santos PS
    Ger Med Sci; 2023; 21():Doc07. PubMed ID: 37426884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
    Bonn EL; Rohrhofer A; Audebert FX; Lang H; Auer DL; Scholz KJ; Schuster P; Wenzel JJ; Hiller KA; Buchalla W; Gottsauner JM; Vielsmeier V; Schmidt B; Cieplik F
    J Dent Res; 2023 Jun; 102(6):608-615. PubMed ID: 36942423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary and Nasal Detection of the SARS-CoV-2 Virus After Antiviral Mouthrinses (BBCovid): A structured summary of a study protocol for a randomised controlled trial.
    Carrouel F; Viennot S; Valette M; Cohen JM; Dussart C; Bourgeois D
    Trials; 2020 Nov; 21(1):906. PubMed ID: 33138848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of a mouthwash containing an antiviral phthalocyanine derivative on the length of hospital stay for COVID-19: randomised trial.
    da Silva Santos PS; da Fonseca Orcina B; Machado RRG; Vilhena FV; da Costa Alves LM; Zangrando MSR; de Oliveira RC; Soares MQS; Simão ANC; Pietro ECIN; Kuroda JPG; de Almeida Benjamim IA; Araujo DB; Toma SH; Flor L; Araki K; Durigon EL
    Sci Rep; 2021 Oct; 11(1):19937. PubMed ID: 34620904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Povidone-Iodine Nasal Spray on Nasopharyngeal SARS-CoV-2 Viral Load: A Randomized Control Trial.
    Zarabanda D; Vukkadala N; Phillips KM; Qian ZJ; Mfuh KO; Hatter MJ; Lee IT; Rao VK; Hwang PH; Domb G; Patel ZM; Pinsky BA; Nayak JV
    Laryngoscope; 2022 Nov; 132(11):2089-2095. PubMed ID: 34724213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial.
    Sánchez Barrueco Á; Mateos-Moreno MV; Martínez-Beneyto Y; García-Vázquez E; Campos González A; Zapardiel Ferrero J; Bogoya Castaño A; Alcalá Rueda I; Villacampa Aubá JM; Cenjor Español C; Moreno-Parrado L; Ausina-Márquez V; García-Esteban S; Artacho A; López-Labrador FX; Mira A; Ferrer MD
    Emerg Microbes Infect; 2022 Dec; 11(1):1833-1842. PubMed ID: 35796097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mouthwashes for asymptomatic to mildly symptomatic adults with COVID-19 and salivary viral load: a randomized, placebo-controlled, open-label clinical trial.
    Onozuka D; Takatera S; Matsuo H; Yoshida H; Hamaguchi S; Yamamoto S; Sada RM; Suzuki K; Konishi K; Kutsuna S
    BMC Oral Health; 2024 Apr; 24(1):491. PubMed ID: 38664718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19: A Randomized Clinical Trial.
    Guenezan J; Garcia M; Strasters D; Jousselin C; Lévêque N; Frasca D; Mimoz O
    JAMA Otolaryngol Head Neck Surg; 2021 Apr; 147(4):400-401. PubMed ID: 33538761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of oral antiseptics on the viral load of SARS-CoV-2: A randomized controlled trial.
    Sevinç Gül SN; Dilsiz A; Sağlık İ; Aydın NN
    Dent Med Probl; 2022; 59(3):357-363. PubMed ID: 35904769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective early strategy to prevent olfactory and gustatory dysfunction in COVID-19: a randomized controlled trial.
    Jing Q; Song J; An G; Zhu E; Ai Z; Xiong L; Li C
    QJM; 2024 Jun; 117(5):348-352. PubMed ID: 37988146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
    Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
    J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of mouthwash on reducing salivary SARS-CoV-2 viral load and clinical symptoms: a systematic review and meta-analysis.
    Zhang M; Meng N; Duo H; Yang Y; Dong Q; Gu J
    BMC Infect Dis; 2023 Oct; 23(1):678. PubMed ID: 37821800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of hydrogen peroxide as auxiliary treatment for hospitalized COVID-19 patients in Brazil: preliminary results of a randomized double-blind clinical trial.
    Di Domênico MB; Cesca H; Ponciano THJ; Dos Santos RB; Lenz U; Antunes VP; Godinho VW; Collares K; Corazza PH
    Epidemiol Health; 2021; 43():e2021032. PubMed ID: 33957025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial.
    Carrouel F; Valette M; Gadea E; Esparcieux A; Illes G; Langlois ME; Perrier H; Dussart C; Tramini P; Ribaud M; Bouscambert-Duchamp M; Bourgeois D
    Clin Microbiol Infect; 2021 Oct; 27(10):1494-1501. PubMed ID: 34044151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials.
    D'Amico F; Moro M; Saracino M; Marmiere M; Cilona MB; Lloyd-Jones G; Zangrillo A
    Mol Oral Microbiol; 2023 Jun; 38(3):171-180. PubMed ID: 36808889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USE OF MOUTHWASH AND DENTIFRICE CONTAINING AN ANTIMICROBIAL PHTHALOCYANINE DERIVATIVE FOR THE REDUCTION OF CLINICAL SYMPTOMS OF COVID-19: A RANDOMIZED TRIPLE-BLIND CLINICAL TRIAL.
    Poleti ML; Gregório D; Bistaffa AGI; Fernandes KBP; Vilhena FV; Santos PSDS; Simão ANC; Lozovoy MAB; Tatibana BT; Fernandes TMF
    J Evid Based Dent Pract; 2022 Dec; 22(4):101777. PubMed ID: 36494114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of three antimicrobial mouthwashes in reducing SARS-CoV-2 viral load in the saliva of hospitalized patients: a randomized controlled pilot study.
    Perussolo J; Teh MT; Gkranias N; Tiberi S; Petrie A; Cutino-Moguel MT; Donos N
    Sci Rep; 2023 Aug; 13(1):12647. PubMed ID: 37542087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chlorhexidine mouthwash reduces the salivary viral load of SARS-CoV-2: A randomized clinical trial.
    Costa DD; Brites C; Vaz SN; de Santana DS; Dos Santos JN; Cury PR
    Oral Dis; 2022 Nov; 28 Suppl 2():2500-2508. PubMed ID: 34837305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of SARS-CoV-2 viral load in saliva after rinsing with mouthwashes containing cetylpyridinium chloride: a randomized clinical study.
    Bezinelli LM; Corrêa L; Beyerstedt S; Franco ML; Rangel ÉB; Benítez CG; Hamerschlak N; Pinho JRR; Heller D; Eduardo FP
    PeerJ; 2023; 11():e15080. PubMed ID: 38130922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.